Title: Women
1- Womens Health and the Media
- Where do we find trustworthy information?
2- What are the key challenges?
- Media portrayals of new medical research often
inaccurate - A societal embracing of the quick fix or pill
for every ill approach
3- Key Challenges.
- Increasing influence of the pharmaceutical
industry over physician prescribing practices as
well as the educational and advertising materials
aimed at the consumer or patient
4- Amidst the plethora of websites, ads and other
sources, how does one find trustworthy
information?
5- Know the source of your information and look out
for conflicts of interest - Utilize non-commercial websites prepared by those
who know how to evaluate the quality of the
research that they cite - Use more than one source
6- EXAMPLE OF CHILDBIRTH AND THE RISING CESAREAN
SECTION RATES IN THE UNITED STATES
7Reasons for Rising Cesarean Rates(IOM 1989
report)
- 30 of the rise due to diagnosis of dystocia
(abnormal or difficult labor) - 25-30 due to repeat cesarean section
- 10-25 due to breech presentation
- 10-15 due to fetal distress
8Current reasons for rising cesarean rates
- Primarily changes in obstetrical practice, such
as - - More repeat cesareans
- - More refusals to allow VBACs
- - Concerns about malpractice
- - More advocates of medically- unnecessary
cesareans
9- NCHS TRACKING IN 2004
- Cesarean delivery rate rose 6 percent in 2004 to
29.1 percent of all births, the highest rate ever
reported in the United States - From http//www.cdc.gov/nchs/products/pubs/pubd/h
estats/prelimbirths04/prelimbirths04health.htm
10TRACKING in 2004 (cont.)The rate has
increased by over 40 percent since 1996. For
200304 the primary cesarean rate rose 8 percent,
and the rate of vaginal birth after cesarean
delivery (VBAC) dropped 13 percent. The primary
rate has climbed 41 percent and the VBAC rate has
fallen 67 percent since 1996.
11NIH Meetingon Cesareans by Maternal Request
(March 27-29, 2006)Will media coverage of this
meeting and its report result in more cesareans
with no medical indication (elective surgery)?
12- QUESTIONS ADDRESSED AT THE NIH MEETING
- What is the trend and incidence of cesarean
delivery in the US and other countries? - What are the benefits and harms of cesarean by
request vs. attempted vaginal birth (both
short-term and long-term)?
(Cont.)
13QUESTIONS (cont.)
- What factors influence benefits and harms?
- What research should be done to get better
evidence for making decisions regarding cesarean
delivery on request vs. attempted vaginal
delivery?
14Panels RecommendationsFinal report at
www.consensus.nih.gov/2006
- Insufficient evidence, so more research needed on
benefits and risks of cesarean delivery on
maternal request vs. planned vaginal delivery - Until better evidence is available, any decision
to do cesareans upon maternal request should be
carefully considered
15Recommendations (cont.)
- Not recommended for women desiring several
children given rising risks of placenta previa
and accreta with each cesarean delivery - No cesareans upon maternal request prior to 39
weeks or without verification of lung maturity
(because of significant risks of neonatal
respiratory complications)
16Recommendations (cont.)
- Effective pain management services should be
available for all women so that fear of pain is
not a motivating factor for an elective cesarean - NIH (or other appropriate Federal agency)
establish a website with up-to-date information
17- The final report did not adequately consider
many recognized long-term adverse outcomes
associated with cesarean surgery and did not take
into account the impact that avoidable obstetric
practices can cause during vaginal birth.
18- From the national Listening to Mothers II Survey
of the Childbirth Connection in NYC
(http//www.childbirthconnection.org/article.asp?c
k10401) - 56 of women who wanted a vaginal birth after
having had a cesarean said a doctor denied them
that option. - 1 out of every 4 women polled who had caesarean
said they felt pushed into having the surgery.
19Excellent discussions of this meeting
- Diony Youngs editorial in the September 2006
issue of BIRTH Cesarean Delivery on Maternal
Request Was the NIH Conference Based on a
Faulty Premise? - Henci Goers piece in Lamaze e-news (June 2006)
- Rona McCandlishs article in MIDWIFERY (v.22,
2006) Meeting maternal request for Cesarean
section paving the road to hell?
20Possible consequences of these Recommendations
- An increasing trend towards considering cesarean
birth as a normal birth with benefits/harms on
par with vaginal birth - Misleading coverage in the media
- Continued distortion of the concept of womens
right to choose
21- Maternal mortality and severe morbidity
associated with low-risk planned cesarean
delivery versus planned vaginal delivery at term - Liu et al. CMAJ Feb 2007
-
- (This study used a breech group as a surrogate
for an elective cesarean group)
22- Among healthy women in the study
- 27.3 per 1,000 women in the planned cesarean
group (breech births) had severe complications
(such as major infections or blood clots) vs. 9
per 1,000 women in the planned vaginal group
23- From the CMAJ commentary
- This study provides additional support to a
growing body of evidence suggesting that primary
elective cesarean birth may place both mother and
newborn at greater risk for adverse outcomes than
planned vaginal birth
24- COSMETIC SURGERY is the fastest growing medical
specialty in the U.S.
25-
- Breast implants solely for cosmetic purposes
are increasing in popularity despite substantial
risks associated with both silicone and saline
implants.
26- See the booklet prepared by the US Food and Drug
Administration for photographs and descriptions
of adverse implant outcomes such as
disfigurement, capsular contracture (when the
breast becomes hard and misshapen), and
deflation - www.fda.gov/cdrh/breastimplants)
27Sample Photo from Implant Makers Website
28Photo of Capsular ContractureFrom FDA Booklet
29This is the same 27-year old woman after her
painful implants were removed
30Necrosis in mastectomy patient with implants for
one week
31After removal of one womans leaking silicone
implants
32- According to the American Society for Aesthetic
Plastic Surgery, 364,610 women got breast
implants in 2005. The number was up 9 percent
from 2004.
33-
- It's like being set free, from being trapped in
a bad body, to being set free in a nice body. - From More women having mommy makeovers by
Kim BaerThe Free Lance-Star - (Fredericksburg, VA) March 13, 2007
34- A survey by the American Society of Plastic
Surgeons showed that nearly 40 percent of plastic
surgery patients believe they should have been
more proactive in learning about potential side
effects and complications before surgery.
35There are over-the counter creams and lotions.
And then theres Botox Cosmetic. My doctor says
theyre just not the same. She said only
prescription Botox is approved by the FDA to
treat the frown lines between your brows
36- A large coalition of groups
- See www.safecosmetics.org
- Skin Deep a report of the Environmental
Working Group, helps consumers and workers to
better protect themselves from known or suspected
carcinogens and reproductive toxins.
37In October 2005, Governor Schwarzenegger signed
the Safe Cosmetics Act into California law. As of
January 1, 2007, cosmetics manufacturers in the
state will be required to disclose any product
ingredients that cause cancer or birth defects.
38Harmful Substances to Avoid
- Para-phenylenediamine, a chemical found in some
dark hair dyes (may increase risk for bladder
cancer in humans) - Phthalates, typically used as a solvent and
plastic softener and also found in many shampoos
and other hair products, cosmetics, deodorants
and nail polish (has been linked to cancer and to
birth defects of the male reproductive system).
To learn more, go to www.nottoopretty.org.
39- To avoid (continued)
- Talc, in talcum powder (has been linked to a 60
increase in the risk for ovarian cancer in women
who use it in the genital area). - Propylene glycol, an ingredient found in some
moisturizing products and skin creams (may damage
the kidneys and liver).
40What to do to minimize risk
- Read labels carefully and choose all-natural
alternatives, such as products made with olive
oil, safflower oil or oatmeal, whenever possible.
41- Direct-to-Consumer Advertising of Prescription
Drugs - Misleading Ads and How They Hurt Us
42The Public Gets Misinformation
- Benefits are often overstated, while risks are
understated - FDA warning letters are issued after the ads run
- Corrective ads are rarely required
- Withdrawal of an ad is the only penalty
43- Ads are geared primarily to selling more drug
product, not educating the user - The ads work the most highly advertised drugs,
accompanied by promotional campaigns geared to
physicians, sell extremely well
44- Top selling drug in the world?
-
45- Lipitor (Pfizer)
- (with more than 13 billion dollars in sales in
2005)
46-
- Drugs can be quite useful, but Pills for
Prevention may not be the best approach.
47- Important to promote a view of public health
that stresses primary prevention identifying
and eliminating disease-causing agents in our
food, water, and air.
48- Precautionary Principle of Public Health
- When an activity raises threats of harm to the
environment or human health, precautionary
measures should be taken even if some cause and
effect relationships are not fully established. - Science and Environmental Health Network
www.sehn.org
49- Consider the example of an ad for SARAFEM
(Prozac repackaged as a pink and purple capsule)
at www.sarafem.com - (ad since removed)
-
50- Think its PMS? Think Againit could be PMDD
- Picture of a young woman trying to zip her
jeans (too bloated?) picture of another woman
seemingly distressed - Then text follows
51- Irritability, sadness, sudden mood changes,
tension, bloating. If you suffer from many of
these symptoms month after month and they clearly
interfere with your daily activities and
relationships you could have PMDD
52- PMDD, Premenstrual Dysphoric Disorder, is a
distinct medical condition that is characterized
by intense mood and physical symptoms right
before your period.
53Sarafem can help. Doctors can treat PMDD with
medication for PMDD
- Constantly flashing, each shown consecutively
- Mood swings---irritability---bloated feeling
54- Drug regulators in Europe forced Eli Lilly to
drop PMDD as one of the approved uses for Prozac
(Sarafem), as the data did not provide adequate
evidence of efficacy.
55- Current content at this website has changed.
Sample quote - Many physicians believe that Sarafem helps to
correct the imbalance of serotonin that could
contribute to PMDD.
56- Antidepressants increased the risk of suicidal
thinking and behavior in children and teenagers
with depression and other psychiatric disorders. - Patients starting therapy should be observed
closely for worsening depression symptoms,
suicidal thoughts or behavior, or unusual changes
in behavior. - Sarafem is not approved for use in patients
under the age of 18.
57(No Transcript)
58- The ad was misleading because it mixed
relative risk with absolute risk, noting, for
example, the following - 44 fewer breast cancers in women taking
tamoxifen vs. women taking a placebo - But there was NO mention of the following
relative risk a 252 increased risk of
endometrial cancer
59- The ad also noted a risk of serious problems
such as endometrial cancer or blood clots at
only 1-2 (absolute risk) - But left out was any mention that women have
only a 1.8 chance of benefiting from the drug
(absolute benefit)
60- Unpaid advertising also a problem
- Parade magazine, for example, put model Lauren
Hutton on its cover for a piece on celebrity
beauty tips, and quoted her saying her "No. 1
secret is estrogen. Its good for your moods,
its good for your skin. If I had to choose
between all my creams and makeup for feeling and
looking good, Id take the estrogen.
61-
- The article didnt mention that Hutton was a
paid spokesperson for Wyeth Ayerst, and that she
appeared in their ads. It also didnt mention
that Hutton's claims for estrogen's benefits were
not backed up by valid scientific evidence.
62- Female Sexual Dysfunction
- Is this a serious problem requiring primarily
biomedical solutions, or is a different approach
most often called for?
63In 1999, Pfizer consultants analyzed one question
from a 1994 survey and produced an overly
simplistic conclusion that 43 of American
women suffer from sexual dysfunction
64- Idea Marketing
- A disease awareness campaign is now building a
drug market usingthe 43 FSD statistic. - (Slide Courtesy of Leonore Tiefer)
65To promote The Hunt for the
Pink Viagra(Slide Courtesy of Leonore
Tiefer)
66- For more information about female sexual
problems, see the website of the Campaign for a
New View of Womens Sexual Problems -
- www.fsd-alert.org
67Menopause
Every day 5,000 women in the U.S. enter
menopause, the so-called change of life
68What do we think about menopause?
- Some women see it as the end of sex or the end
of youth - Some see a passport to freedom (no fear of
getting pregnant, no messing with pads and
tampons, no more shoulds about how one needs to
look) - Possibly more time for oneself
69What influences our thinking?
- Media messages that worship youth, thinness, and
suggest its not OK to grow old - Conversations with other women about their actual
experiences with menoapuse
70Opportunities for Medicalization
- Less/no interest in sex
- Hot flashes/vaginal dryness and loss of
elasticity - Loss of bone density
71- More spreading waistlines and sagging skin
- Memory problems
- Depression
- Problems with sleep
72- Approaches to dealing with sleep problems other
than prescription sleeping drugs such as Ambien
and Lunesta - Yoga/exercise
- Avoiding caffeine
- Deep breathing/massage at bedtime from a partner
- Sleep in a cool room
73Non-hormonal approaches to dealing with hot
flashes
- Wear layered clothing
- Use fans
- Put palms or bare feet on a cold surface
- Cold pack under the pillow
- Exercise, yoga, deep breathing
- Less caffeine, less spicy foods, less alcohol
(especially red wine)
74Removing health ovaries
-
- US federal data from the late 1990s
- 78 of women 45-64 who have had a hysterectomy
also had healthy ovaries removed (even though
most were not at particular risk of developing
ovarian cancer).
75- Latest research shows that for women without a
family history of ovarian cancer there is a
significant reduction in death from heart disease
and complications of osteoporosis IF THE OVARIES
ARE KEPT, especially until the age of 65.
76- KEY FINDINGS OF WILLIAM PARKER et al study in
2005 - For 10,000 women 50-54 yrs old who undergo a
hysterectomy with oophorectomy, there will be 47
fewer cases of ovarian cancer by the time these
women reach 80 when compared with a similar group
who keep their ovaries.
77- BUT the oophorectomy group will suffer 838
additional deaths from coronary heart disease as
well as 158 more deaths from hip fractures.
(Numbers reflect women who do NOT have estrogen
therapy there is a smaller survival benefit to
keeping the ovaries in women taking estrogen.)
78- Ads for bone density screening now pitched at
women around 50 yrs of age - Creation of the T score and a new
classification called osteopenia (for -1 to -2.5
scores) - Merck stopped by the FDA from using the claim
menopause is the single most important cause of
osteoporosis in their ads
79Cloning, Stem Cells and Inheritable Genetic
ModificationSpecial case of embryo cloning
(somatic cell nuclear transfer)
80Research the promises and the challenges
- Balancing our interest in developing new medical
therapies with the need to protect research
subjects and the need to preserve values of
social justice and equity - Developing technologies that will be accessible
to most
81- Often Ignored Concerns
- Risks to womens health
- Gateway to designer babies
- Unethical experimentation on humans
- Fueling of a new eugenics movement
82Risks to Womens Health from Research Cloning
-
- Also known as therapeutic cloning or somatic
cell nuclear transfer (SCNT), SCNT requires the
collection of many eggs from women willing to
undergo egg extraction procedures.
83Some Concerns about Multiple Egg Extraction
- Use of leuprolide acetate (Lupron), a GnRH
agonist, to shut down the ovaries, is not
FDA-aproved for this purpose (Antagon, a GnRH
antagonist that is also used, is approved for
this use.) - Use of drugs that hyper-stimulate the ovaries to
produce multiple follicles
84- As Spring of 1999, US Food and Drug
Administration (FDA) had received 4228 reports of
adverse drug events from women using Lupron.
325 of the adverse events for women reported to
the FDA resulted in hospitalization, and
additionally, 25 deaths were reported.
85The Research Cloning Debate
- The most vocal participants have been
- Anti-choice conservatives opposed to the
destruction of embryos, who favor a permanent ban - Biomedical researchers and their allies, who are
wary of or opposed to regulatory oversight
86Good Resources
- National Womens Health Network (DC)
- Breast Cancer Action (SF)
- Collaborative on Health and the Environment
- Science and Environmental Health Network
- Silent Spring Institute (Newton, MA)
- Teen Voices magazine (Boston)
- Center for Medical Consumers (NYC)
- Canadian Womens Health Network (CWHN)
- www.ourbodiesourselves.org
87(No Transcript)
88- www.ourbodiesourselves.org
- May 2005
89(No Transcript)